表紙
市場調查報告書

介入性腫瘤學市場:手術,產品,用途,各終端用戶的全球市場預測

Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 906594
出版日期 內容資訊 英文 251 Pages
訂單完成後即時交付
價格
Back to Top
介入性腫瘤學市場:手術,產品,用途,各終端用戶的全球市場預測 Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025
出版日期: 2019年08月13日內容資訊: 英文 251 Pages
簡介

本報告提供全球介入性腫瘤學市場相關調查,提供市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
  • 阻礙市場的要素
  • 機會
  • 趨勢

第5章 各手術市場

  • 簡介
  • 腫瘤栓塞
  • 腫瘤切除

第6章 各產品市場

  • 簡介
  • 腫瘤栓塞
  • 腫瘤切除

第7章 各用途市場

  • 簡介
  • 肝癌
  • 肺癌
  • 乳癌
  • 前列腺癌
  • 腎臟癌
  • 骨轉移
  • 其他

第8章 各終端用戶市場

  • 簡介
  • 醫院
  • 門診外科中心
  • 研究·學術機構

第9章 各地區市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭環境

  • 成長策略
  • 競爭基準
  • 市場佔有率分析

第11章 企業簡介

第12章 附錄

目錄

Title:
Interventional oncology Market
by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation)], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User- Global Forecast to 2025.

The global interventional oncology market is estimated to grow at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025.

Succeeding an extensive secondary and primary research and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, challenges, and opportunities. The factors such as growing preference for minimally invasive treatment procedures, increasing incidence of cancer, rising number of hospitals, and technological advancements in the field of radiology - are driving the growth of global interventional oncology market. However, high cost and risks associated with the interventional oncology procedures and paucity of skilled healthcare professionals hinders the growth of this market.

The global interventional oncology market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by procedure (embolization [TARE, TACE], ablation thermal ablation [microwave, RF ablation]), by product (embolization [SIR-spheres, theraspheres], ablation), application (liver, lung, breast), end user (hospitals, ambulatory care center), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Embolization products segment is estimated to command the largest share of the global interventional oncology market in 2019 and expected to witness high growth during the forecast period mainly due to the preference for embolization procedures owing to its benefits such as better clinical outcomes, high specificity & sensitivity towards tumor cells, and efficiency in targeting and detection of tumor lesions. However, fastest growth in this market is majorly driven by increasing application base of embolization products across various cancer types, rising coverage of reimbursement across the globe, and increasing incidence of cancer & related mortality.

The interventional oncology market for hospitals (end user segment) is estimated to command the largest share of the global market in 2019. This is attributed to large volume of patients visiting hospitals for diagnosis & treatment of any healthcare concern including a critical disease like cancer owing to the wide presence, easy accessibility and better healthcare facilities in hospitals.

An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global interventional oncology market, mainly attributed to the factors such as well-established healthcare system including hospitals and ASCs in the North American region, greater adoption of advanced technologies, high level of awareness & spending towards overall healthcare and cancer, growing incidence & prevalence of cancer, presence of key players, and high level of Medicare & Medicaid health insurance coverage.

Key players operating in the global interventional oncology market are: Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

Scope of the Report:

Market by Procedure

  • Tumor Embolization
    • Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
    • Transcatheter Arterial Chemoembolization (TACE)
    • Transcatheter Arterial embolization/Bland Embolization
  • Tumor ablation
    • Thermal Ablation
      • Microwave Ablation
      • Radiofrequency Ablation
      • Cryoablation
      • Others (Laser and HIFU)
    • Non-thermal Ablation
      • Irreversible Electroporation

Market by Product

  • Tumor Embolization
    • Radioembolic agents
      • SIR-Spheres
      • TheraSphere
      • QuiremSpheres
    • Non-radioactive embolic agents
      • Microspheres
      • Drug-eluting beads
      • Particles
    • Tumor Ablation
      • Capital Ablation Devices/Generators
      • Consumables & Accessories

Market by Application

  • Liver Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Market by End user

  • Hospital
  • Ambulatory Care Centers
  • Research & Academia

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • India
    • Japan
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Secondary Research
  • 2.2. Primary Research

3. Executive Summary

4. Market insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Growing Preference for Minimally invasive Treatment Procedures
      • 4.2.1.2. Increasing Incidence & Prevalence of Cancer
      • 4.2.1.3. Rising Number of Hospitals
      • 4.2.1.4. Technological Advancements in the Field of Radiology
    • 4.2.2. Restraints
      • 4.2.2.1. Potential Risks Associated with Interventional Oncology Procedures
      • 4.2.2.2. High Cost Associated with Interventional Oncology Procedures
      • 4.2.2.3. Paucity of Skilled Healthcare Professionals
    • 4.2.3. Opportunities
      • 4.2.3.1. Significant Growth Opportunities from Emerging Asian and Latin American Markets
      • 4.2.3.2. Introduction of Cloud-Based Medical Imaging
    • 4.2.4. Trend
      • 4.2.4.1. Growing Integration of Image-Guided Solutions with Interventional Oncology Procedures

5. Interventional Oncology Market, by Procedure

  • 5.1. Introduction
  • 5.2. Tumor Embolization
    • 5.2.1. Transarterial Radioembolization (TARE)
    • 5.2.2. Transarterial Chemoembolization (TACE)
    • 5.2.3. Bland Embolization
  • 5.3. Tumor Ablation
    • 5.3.1. Thermal Ablation
      • 5.3.1.1. Radiofrequency Ablation (RFA)
      • 5.3.1.2. Microwave Ablation (MWA)
      • 5.3.1.3. Cryoablation
      • 5.3.1.4. Other Thermal Ablation Procedures
    • 5.3.2. Non-Thermal Ablation

6. Interventional Oncology Market, by Product

  • 6.1. Introduction
  • 6.2. Tumor Embolization
    • 6.2.1. Radioembolic Agents
      • 6.2.1.1. Sir-Spheres
      • 6.2.1.2. TheraSphere
      • 6.2.1.3. QuiremSpheres
    • 6.2.2. Non-Radioactive Embolic Agents
      • 6.2.2.1. Microspheres
      • 6.2.2.2. Particles (PVA Particles and Gelfoam Particles)
      • 6.2.2.3. Drug-Eluting Beads (DEBs)
  • 6.3. Tumor Ablation
    • 6.3.1. Tumor Ablation Devices/Generators
    • 6.3.2. Consumables & Accessories

7. Interventional Oncology Market, by Application

  • 7.1. Introduction
  • 7.2. Liver Cancer
  • 7.3. Lung Cancer
  • 7.4. Breast Cancer
  • 7.5. Prostate Cancer
  • 7.6. Kidney Cancer
  • 7.7. Bone Metastasis
  • 7.8. Other Cancers

8. Interventional Oncology Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgery Centres
  • 8.4. Research and Academia

9. Interventional Oncology Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Rest of World
    • 9.5.1. Latin America
    • 9.5.2. Middle East & Africa

10. Competitive Landscape

  • 10.1. Growth Strategies
  • 10.2. Competitive Benchmarking
  • 10.3. Market Share Analysis (2018)

11. Company Profiles(Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 11.1. Boston Scientific Corporation
  • 11.2. Cook Medical LLC (A Subsidiary of Cook Group)
  • 11.3. Merit Medical Systems, Inc.
  • 11.4. C. R. Bard, Inc. (A Subsidiary of Becton Dickinson & Company)
  • 11.5. Profound Medical Corp.
  • 11.6. AngioDynamics, Inc.
  • 11.7. BTG plc
  • 11.8. Terumo Corporation
  • 11.9. Medtronic plc
  • 11.10. Healthtronics, Inc.
  • 11.11. EDAP TMS S.A.
  • 11.12. Neuwave Medical, Inc. (Subsidiary of Ethicon Inc.)
  • 11.13. Sirtex Medical Limited
  • 11.14. Trod Medical
  • 11.15. Teleflex Incorporated
  • 11.16. IMBiotechnologies Ltd.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1: Global Interventional Oncology Market Drivers: Impact Analysis (2019-2025)
  • Table 2: Global Interventional Oncology Market Restraints: Impact Analysis (2019-2025)
  • Table 3: Cost of Ablation Treatment (For 3cm Kidney Lesion)
  • Table 4: Global Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 5: Global Tumor Embolization Market Size, by Type, 2017-2025 ($Million)
  • Table 6: Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
  • Table 7: Global Transarterial Radioembolization Market Size, by Country, 2017-2025 ($Million)
  • Table 8: Global Transarterial Chemoembolization Market Size, by Country, 2017-2025 ($Million)
  • Table 9: Global Bland Embolization Market Size, by Country, 2017-2025 ($Million)
  • Table 10: Global Tumor Ablation Market Size, by Type, 2017-2025 ($Million)
  • Table 11: Global Tumor Ablation Market Size, by Country, 2017-2025 ($Million)
  • Table 12: Global Thermal Ablation Market Size, by Type, 2017-2025 ($Million)
  • Table 13: Global Thermal Ablation Market Size, by Country, 2017-2025 ($Million)
  • Table 14: Global Radiofrequency Ablation Market Size, by Country, 2017-2025 ($Million)
  • Table 15: Global Microwave Ablation Market Size, by Country, 2017-2025 ($Million)
  • Table 16: Global Cryoablation Market Size, by Country, 2017-2025 ($Million)
  • Table 17: Global Other Thermal Ablation Procedures Market Size, by Country, 2017-2024 ($Million)
  • Table 18: Global Irreversible Electroporation Market Size, by Country, 2017-2024 ($Million)
  • Table 19: Global Interventional Oncology Market Size, by Product, 2017-2025 ($Million)
  • Table 20: Global Tumor Embolization Market Size, by Product Type, 2017-2025 ($Million)
  • Table 21: Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
  • Table 22: List of Commercialized Radioembolic Agents
  • Table 23: Global Radioembolic Agents Market Size, by Product, 2017-2025 ($Million)
  • Table 24: Global Radioembolic Agents Market Size, by Country, 2017-2025 ($Million)
  • Table 25: Global Non-Radioactive Embolic Agents Market Size, by Type, 2017-2025 ($Million)
  • Table 26: Global Non-Radioactive Embolic Agents Market Size, by Country, 2017-2025 ($Million)
  • Table 27: Global Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 28: Global Tumor Ablation Market, by Country, 2017-2025 ($Million)
  • Table 29: Global Tumor Ablation Devices/ Generators Market Size, by Country, 2017-2025 ($Million)
  • Table 30: Global Tumor Ablation Consumables & Accessories Market Size, by Country, 2017-2025 ($Million)
  • Table 31: Global Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 32: Global Interventional Oncology Market Size for Liver Cancer, by Country, 2017-2025 ($Million)
  • Table 33: Global Interventional Oncology Market Size for Lung Cancer, by Country, 2017-2025 ($Million)
  • Table 34: Global Interventional Oncology Market Size for Breast Cancer, by Country, 2017-2025 ($Million)
  • Table 35: Examples of Products Used for Prostate Cancer Treatment
  • Table 36: Global Interventional Oncology Market Size for Prostate Cancer, by Country, 2017-2025 ($Million)
  • Table 37: Global Interventional Oncology Market Size for Kidney Cancer, by Country, 2017-2025 ($Million)
  • Table 38: Global Interventional Oncology Market Size for Bone Metastasis, by Country, 2017-2025 ($Million)
  • Table 39: Global Interventional Oncology Market Size for Other Cancers, by Country, 2017-2025 ($Million)
  • Table 40: Global Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 41: Global Interventional Oncology Market Size for Hospitals, by Country, 2017-2025 ($Million)
  • Table 42: Global Interventional Oncology Market Size for Ambulatory Surgery Centres, by Country, 2017-2025 ($Million)
  • Table 43: Global Interventional Oncology Market Size for Research and Academia, by Country, 2017-2025 ($Million)
  • Table 44: Global Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
  • Table 45: North America: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
  • Table 46: North America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 47: North America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 48: North America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 49: North America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 50: North America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 51: North America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 52: North America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 53: North America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 54: U.S.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 55: U.S.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 56: U.S.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 57: U.S.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 58: U.S.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 59: U.S.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 60: U.S.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 61: U.S.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 62: Canada: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 63: Canada: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 64: Canada: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 65: Canada: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 66: Canada: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 67: Canada: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 68: Canada: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 69: Canada: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 70: Europe: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
  • Table 71: Europe: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 72: Europe: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 73: Europe: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 74: Europe: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 75: Europe: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 76: Europe: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 77: Europe: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 78: Europe: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 79: Germany: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 80: Germany: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 81: Germany: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 82: Germany: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 83: Germany: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 84: Germany: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 85: Germany: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 86: Germany: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 87: France: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 88: France: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 89: France: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 90: France: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 91: France: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 92: France: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 93: France: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 94: France: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 95: U.K.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 96: U.K.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 97: U.K.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 98: U.K.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 99: U.K.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 100: U.K.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 101: U.K.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 102: U.K.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 103: Italy: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 104: Italy: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 105: Italy: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 106: Italy: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 107: Italy: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 108: Italy: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 109: Italy: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 110: Italy: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 111: Spain: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 112: Spain: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 113: Spain: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 114: Spain: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 115: Spain: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 116: Spain: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 117: Spain: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 118: Spain: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 119: Interventional Oncology Conferences
  • Table 120: RoE: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 121: RoE: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 122: RoE: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 123: RoE: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 124: RoE: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 125: RoE: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 126: RoE: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 127: RoE: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 128: Asia-Pacific: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
  • Table 129: Asia-Pacific: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 130: Asia-Pacific: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 131: Asia-Pacific: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 132: Asia-Pacific: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 133: Asia-Pacific: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 134: Asia-Pacific: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 135: Asia-Pacific: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 136: Asia-Pacific: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 137: Japan: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 138: Japan: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 139: Japan: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 140: Japan: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 141: Japan: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 142: Japan: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 143: Japan: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 144: Japan: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 145: China: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 146: China: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 147: China: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 148: China: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 149: China: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 150: China: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 151: China: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 152: China: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 153: India: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 154: India: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 155: India: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 156: India: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 157: India: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 158: India: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 159: India: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 160: India: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 161: RoAPAC: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 162: RoAPAC: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 163: RoAPAC: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 164: RoAPAC: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 165: RoAPAC: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 166: RoAPAC: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 167: RoAPAC: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 168: RoAPAC: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 169: RoW: Interventional Oncology Market Size, by Region, 2017-2025 ($Million)
  • Table 170: RoW: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 171: RoW: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 172: RoW: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 173: RoW: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 174: RoW: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 175: RoW: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 176: RoW: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 177: RoW: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 178: Latin America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 179: Latin America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 180: Latin America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 181: Latin America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 182: Latin America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 183: Latin America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 184: Latin America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 185: Latin America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 186: Cancer Incidence in Middle East and Africa, 2012-2030 (Number of New Cases)
  • Table 187: Interventional Oncology Conferences in Middle East & Africa
  • Table 188: Middle East & Africa: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
  • Table 189: Middle East & Africa: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
  • Table 190: Middle East & Africa: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
  • Table 191: Middle East & Africa: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
  • Table 192: Middle East & Africa: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
  • Table 193: Middle East & Africa: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
  • Table 194: Middle East & Africa: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
  • Table 195: Middle East & Africa: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
  • Table 196: Number of Developments by the Major Players During 2016-2019
  • Table 197: Interventional Oncology: Competitive Benchmarking

List of Figures

  • Figure 1: Research Process
  • Figure 2: Key Executives Interviewed
  • Figure 3: Primary Research Techniques
  • Figure 4: Market Size Estimation
  • Figure 5: Tumor Embolization Segment Dominates the Global Interventional Oncology Market
  • Figure 6: Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
  • Figure 7: Global Interventional Oncology Market, by End User, 2019-2025 ($ Million)
  • Figure 8: Global Interventional Oncology Market Overview: 2019-2025
  • Figure 9: Number of Embolization Procedures Performed Globally for Treatment of Liver Cancer, 2016-2027 (In Thousands)
  • Figure 10: Number of Ablation Procedures Performed Globally, 2016-2027 (In Thousands)
  • Figure 11: Number of New Cancer Cases Across the Globe, 2012-2040 (In Million)
  • Figure 12: Cancer Related Deaths Globally, 2012-2040 (Cases in Millions)
  • Figure 13: Number of Private Hospitals in Australia: 2011-2012 and 2015-2016
  • Figure 14: Number of Doctors Per 1,000 Population, by Country, 2017
  • Figure 15: Proportion of Population Aged 60 Or Over in Asia, by Region, 2016-2050
  • Figure 16: Cancer Incidence in Asia: 2018-2040
  • Figure 17: Global Interventional Oncology Market Size, by Procedure, 2019-2025 ($Million)
  • Figure 18: Global Interventional Oncology Market Size, by Product, 2019-2025 ($Million)
  • Figure 19: Global Sir-Spheres Market Size, 2017-2025 ($Million)
  • Figure 20: Global TheraSphere Market Size, 2017-2025 ($Million)
  • Figure 21: Global QuiremSpheres Market Size, 2017-2025 ($Million)
  • Figure 22: Global Microspheres Market Size, 2017-2025 ($Million)
  • Figure 23: Global Embolization Particles Market Size, 2017-2025 ($Million)
  • Figure 24: Global Drug-Eluting Beads Market Size, 2017-2025 ($Million)
  • Figure 25: Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
  • Figure 26: Number of New Liver Cancer Cases Worldwide (2012-2018)
  • Figure 27: Number of New Lung Cancer Cases in 2018, by Region (In Thousands)
  • Figure 28: Number of New Breast Cancer Cases Worldwide, (2012-2018)
  • Figure 29: Number of New Prostate Cancer Cases Globally, 2018-2030 (In Millions)
  • Figure 30: Global Incidence of Kidney Cancer, 2012-2018 (Number of Cancer Cases)
  • Figure 31: U.S: Number of New Stomach Cancer Cases and Related Deaths, 2012-2018
  • Figure 32: Global Interventional Oncology Market Size, by End User, 2019-2025 ($Million)
  • Figure 33: Number of Private Hospitals in China ,2013-2017
  • Figure 34: Number of Outpatient Care Centres in the U.S., 2010-2016
  • Figure 35: Number of Medicare-Certified Ambulatory Surgical Centres in U.S., 2009-2014
  • Figure 36: Global Burden of New Cancer Cases Across the World (In Millions)
  • Figure 37: Global Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
  • Figure 38: North America: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
  • Figure 39: Number of New Cancer Cases in the U.S., 2012-2030 (Cases in Million)
  • Figure 40: Mortality from Cancer in the U.S., 2010-2040 (Number of Deaths Due to Cancer)
  • Figure 41: Total Cancer Expenditure in the U.S., 2010 & 2017 ($ Billion):
  • Figure 42: Number of Cancer Cases in Canada: 2017-2030
  • Figure 43: Total Health Expenditure of Canada, 2000-2017 ($ Billions)
  • Figure 44: Cancer Cases in Europe (In Millions): 2012-2040
  • Figure 45: Share of Breast Cancer Screening in Women Aged 50-69 in Europe, by Country, 2016 (%)
  • Figure 46: Europe: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
  • Figure 47: Share of Population Aged 65 and Above (As % of total Population), 2011-2018
  • Figure 48: Cancer Incidence and Mortality in Germany: 2018-2030 (Number of Cases)
  • Figure 49: Cancer Incidence and Mortality in France: 2018- 2040 (Number of Cases)
  • Figure 50: Healthcare Spending Per Capita in France, 2011-2017 ($)
  • Figure 51: Number of New Cancer Cases and Mortality in U.K.:2018-2040
  • Figure 52: Cost of Cancer Care in the U.K., 2011-2021 ($ Billion)
  • Figure 53: Cancer Incidence and Mortality in Italy,2018-2035 (Number of Cases)
  • Figure 54: Population Aged 65 Or Above in Spain (% of total Population
  • Figure 55: Cancer Incidence and Mortality in Spain, 2018-2040 (Number of Cases)
  • Figure 56: Cancer Incidence by Country: 2018-2040 (Number of Cases)
  • Figure 57: Per Capita Health Spending by Country, 2017 (In $PPP)
  • Figure 58: Asia Cancer Incidence by Region, 2012-2040 (Number of Estimated Cases)
  • Figure 59: Asia-Pacific: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
  • Figure 60: Share of Population Aged 65 and Over in Japan, 2000-2030 (% of total Population)
  • Figure 61: Cancer Incidence and Mortality in Japan, 2018-2040 (Number of Cases)
  • Figure 62: Number of New Cancer Cases and Related Mortality in China, 2018-2040 (Number of Cases)
  • Figure 63: Cancer Incidence and Mortality in India, 2018-2030-2040 (Number of Cases)
  • Figure 64: Proportion of Population Aged 60 Or Above in Asia, by Country, 2015-2030
  • Figure 65: Age Adjusted Rate of New Cancer Cases Per 100,000 Population, 2016
  • Figure 66: Cancer Incidence in RoW, by Country, 2018-2030 (Number of New Cases)
  • Figure 67: RoW: Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
  • Figure 68: Cancer Incidence & Related Mortality in Latin America & Caribbean, 2018-2040 (Number of Cases)
  • Figure 69: Interventional Oncology Conferences in Latin America
  • Figure 70: Growth Strategies Adopted by Key Players (2016-2019)
  • Figure 71: Global Interventional Oncology Market Share, by Key Players, 2018 (%)
  • Figure 72: Boston Scientific Corporation: Financial Overview (2016-2018)
  • Figure 73: Merit Medical Systems, Inc.: Financial Overview (2016-2018)
  • Figure 74: Becton, Dickinson, and Company: Financial Overview (2016-2018)
  • Figure 75: Profound Medical Corp.: Financial Overview (2017-2018)
  • Figure 76: Angiodynamics, Inc.: Financial Overview (2016-2018)
  • Figure 77: BTG plc: Financial Overview (2016-2018)
  • Figure 78: Terumo Corporation: Financial Overview (2016-2018)
  • Figure 79: Medtronic plc: Financial Overview (2016-2018)
  • Figure 80: EDAP TMS S.A.: Financial Overview (2016-2018)
  • Figure 81: Johnson & Johnson: Financial Overview (2016-2018)
  • Figure 82: Sirtex Medical Limited: Financial Overview (2015-2017)
  • Figure 83: Teleflex Incorporated: Financial Overview: (2016-2018)
Back to Top